Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03721822 · ClinicalTrials.gov registry record · Phase 1
Imaging Sex Differences in Smoking-Induced Pulmonary Inflammation
A Phase 1 study of Healthy Volunteer and Smoking, Cigarette, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT03721822 is a Phase 1 study of Healthy Volunteer and Smoking, Cigarette that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 100 participants, below the 201-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03721822, a Phase 1 study of Healthy Volunteer and Smoking, Cigarette, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to measure the extent of lung inflammation between different groups of participants using a radioactive tracer called \[18F\]NOS. A radioactive tracer is a type of imaging drug that is labeled with a radioactive tag and injected into the body.
Conditions Studied
Interventions
- DRUG [18F]NOS
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-10-23 |
| Est. Completion | 2026-10-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03721822
The ClinicalTrials.gov registry entry for NCT03721822 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 201-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (50% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Healthy Volunteer appearing as the primary indexed condition, and to 1 intervention - of which [18F]NOS is the first listed.
NCT03721822 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03721822 about?
NCT03721822 is a clinical study titled "Imaging Sex Differences in Smoking-Induced Pulmonary Inflammation". The purpose of this research is to measure the extent of lung inflammation between different groups of participants using a radioactive tracer called \[18F\]NOS. A radioactive tracer is a type of imaging drug that is labeled with a radioactive tag and injected into the body.
What is the current status of trial NCT03721822?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2018-10-23. Estimated completion is 2026-10-23.
What conditions does trial NCT03721822 study?
This clinical trial studies the following conditions: Healthy Volunteer, Smoking, Cigarette, Smoking E-cigarette.
What interventions are being tested in trial NCT03721822?
The interventions under investigation include: [18F]NOS (DRUG).
Who is sponsoring clinical trial NCT03721822?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03721822 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Healthy Volunteer Study
RECRUITING · Phase 1
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors
RECRUITING · Phase 1
-
A First-in-Human Single and Multiple Ascending Dose Study of MT-201
RECRUITING · Phase 1
-
A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants
RECRUITING · Phase 1
-
A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsules of Single and Multiple Ascending Doses in Adult Participants and Single Doses in Adult Asian Participants
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.